APA (7th ed.) Citation

J, W., J, W., W, G., J, L., T, P., E, C., . . . BJ, W. (2025). PlexinD1 is a driver and a therapeutic target in advanced prostate cancer. EMBO molecular medicine, 17(2), 336. https://doi.org/10.1038/s44321-024-00186-z

Chicago Style (17th ed.) Citation

J, Wei, Wang J, Guan W, Li J, Pu T, Corey E, Lin TP, Gao AC, and Wu BJ. "PlexinD1 Is a Driver and a Therapeutic Target in Advanced Prostate Cancer." EMBO Molecular Medicine 17, no. 2 (2025): 336. https://doi.org/10.1038/s44321-024-00186-z.

MLA (9th ed.) Citation

J, Wei, et al. "PlexinD1 Is a Driver and a Therapeutic Target in Advanced Prostate Cancer." EMBO Molecular Medicine, vol. 17, no. 2, 2025, p. 336, https://doi.org/10.1038/s44321-024-00186-z.